Therapeutic strategies for COVID-19: progress and lessons learned
G Li, R Hilgenfeld, R Whitley, E De Clercq - Nature Reviews Drug …, 2023 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …
Heart disease and stroke statistics—2022 update: a report from the American Heart Association
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Heart disease and stroke statistics—2023 update: a report from the American Heart Association
CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2023 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study
SE Daugherty, Y Guo, K Heath, MC Dasmariñas… - bmj, 2021 - bmj.com
Objective To evaluate the excess risk and relative hazards for developing incident clinical
sequelae after the acute phase of SARS-CoV-2 infection in adults aged 18-65. Design …
sequelae after the acute phase of SARS-CoV-2 infection in adults aged 18-65. Design …
Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study
J Hippisley-Cox, M Patone, XW Mei, D Saatci, S Dixon… - bmj, 2021 - bmj.com
Objective To assess the association between covid-19 vaccines and risk of
thrombocytopenia and thromboembolic events in England among adults. Design Self …
thrombocytopenia and thromboembolic events in England among adults. Design Self …
Severe covid-19 pneumonia: pathogenesis and clinical management
AH Attaway, RG Scheraga, A Bhimraj, M Biehl… - bmj, 2021 - bmj.com
Severe covid-19 pneumonia has posed critical challenges for the research and medical
communities. Older age, male sex, and comorbidities increase the risk for severe disease …
communities. Older age, male sex, and comorbidities increase the risk for severe disease …
A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology
Venous thromboembolism (VTE) is the third most common cause of death worldwide. The
incidence of VTE varies according to different countries, ranging from 1–2 per 1000 person …
incidence of VTE varies according to different countries, ranging from 1–2 per 1000 person …
Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is associated with thrombotic complications in …
syndrome coronavirus 2 (SARS-CoV-2) is associated with thrombotic complications in …
[HTML][HTML] Coronavirus (COVID-19) vaccine-induced immune thrombotic thrombocytopenia (VITT)
A Aleem, AJ Nadeem - 2021 - europepmc.org
Objectives: Review the epidemiology of VITT. Describe the pathophysiology and pertinent
clinical features of VITT. Review the treatment options in the management of VITT. Describe …
clinical features of VITT. Review the treatment options in the management of VITT. Describe …
Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease
Abstract Coronavirus disease 2019 (COVID-19) is a global pandemic caused by SARS-CoV-
2 infection and is associated with both acute and chronic disorders affecting the nervous …
2 infection and is associated with both acute and chronic disorders affecting the nervous …